"Cystadenoma, Serous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
| Descriptor ID |
D018293
|
| MeSH Number(s) |
C04.557.470.035.320.240 C04.557.470.590.485.240
|
| Concept/Terms |
Cystadenoma, Serous- Cystadenoma, Serous
- Cystadenomas, Serous
- Serous Cystadenoma
- Serous Cystadenomas
|
Below are MeSH descriptors whose meaning is more general than "Cystadenoma, Serous".
Below are MeSH descriptors whose meaning is more specific than "Cystadenoma, Serous".
This graph shows the total number of publications written about "Cystadenoma, Serous" by people in this website by year, and whether "Cystadenoma, Serous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cystadenoma, Serous" by people in Profiles.
-
High Diagnostic Yield of Fine Needle Biopsy for Pancreatic Serous Cystadenomas-A Multicenter Study. Pancreas. 2025 Apr 01; 54(4):e349-e352.
-
Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. Am J Gastroenterol. 2019 09; 114(9):1539-1549.
-
Clinical decision making in the management of pancreatic cystic neoplasms. Expert Rev Gastroenterol Hepatol. 2013 May; 7(4):353-60.
-
Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg. 2010 May; 251(5):937-45.
-
Fine-needle aspiration of pancreatic serous cystadenoma: cytologic features and diagnostic pitfalls. Cancer. 2006 Aug 25; 108(4):239-49.
-
Conventional and color Doppler sonography in preoperative assessment of ovarian tumors. Int J Gynaecol Obstet. 2006 Jan; 92(1):64-8.
-
Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas. Appl Immunohistochem Mol Morphol. 2004 Jun; 12(2):148-52.
-
Cystic pancreatic neoplasms evaluation by CT and magnetic resonance cholangiopancreatography. Gastrointest Endosc Clin N Am. 2002 Oct; 12(4):657-72.
-
K-ras mutations in M?llerian inclusion cysts associated with serous borderline tumors of the ovary. Gynecol Oncol. 2001 Feb; 80(2):201-6.